Back
Guardant Health 10K Form
Sell
50
GH
Guardant Health
Last Price:
19.42
Seasonality Move:
10.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
Annual Sales: | $563.95M |
---|---|
Cash Flow: | $-82.81M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.30 |
Price / Book: | 13.77 |
Profitability
EPS (TTM): | -4.28000 |
---|---|
Net Income (TTM): | $-479.45M |
Gross Margin: | $336.9M |
Return on Equity: | -344.76% |
Return on Assets: | -28.05% |
Guardant Health Earnings Forecast
Key Guardant Health Financial Ratios
- The Gross Profit Margin over the past 8 years for GH is 59.74%.
- The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
- The Research & Development expenses have been 65.11% of Revenue.
- The Interest Expense is -0.54% of Operating Income.
- The Net Earning history of GH is -85.02% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 2 years.
Guardant Health Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Diagnostics & Research |
Sector: | Healthcare |
Current Symbol: | GH |
CUSIP: | 40131M |
Website: | guardanthealth.com |
Debt
Debt-to-Equity Ratio: | 7.18 |
---|---|
Current Ratio: | 6.54 |
Quick Ratio: | 6.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
GH Technical Analysis vs Fundamental Analysis
Sell
50
Guardant Health (GH)
is a Sell
Is Guardant Health a Buy or a Sell?
-
Guardant Health stock is rated a Sell
The current Guardant Health [GH] share price is $17.95. The Score for GH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.